Simon Farrell's Form 4 filing
Trevi Therapeutics, Inc. (TRVI) · filed Mar 12, 2025
- Accession no.
- 0000950170-25-037880
- Filed
- Mar 12, 2025
- Trade date
- Mar 10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $549.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simon FarrellCIK 0001965585 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | MOption exerciseAcquired | +17,500 | $3.21 | +$56,175 | 63,150 | Direct | |
| Mar 10, 2025 | Common Stock | MOption exerciseAcquired | +63,813 | $3.91 | +$249,508.83 | 126,963 | Direct | |
| Mar 10, 2025 | Common Stock | MOption exerciseAcquired | +31,250 | $0.51 | +$15,937.5 | 158,213 | Direct | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −76,963 | $6.73 | −$517,960.99 | 81,250 | Direct | |
| Mar 10, 2025 | Common Stock | SSaleDisposed | −4,350 | $7.15 | −$31,102.5 | 76,900 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | AGrant or awardAcquired | +38,400 | $0.00 | $0 | 38,400 | Direct | |
| Mar 10, 2025 | Common Stock | MOption exerciseDisposed | −17,500 | $0.00 | $0 | 0 | Direct | |
| Mar 10, 2025 | Common Stock | MOption exerciseDisposed | −63,813 | $0.00 | $0 | 11,187 | Direct | |
| Mar 10, 2025 | Common Stock | MOption exerciseDisposed | −31,250 | $0.00 | $0 | 18,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.